30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Api Acquisition Sub Inc (AVRX)

Track

Stock chart
Ticker: AVRX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Carter Kenneth C
President and CEO
9 purchases — total 12,485 USD
Buy 23 Jan 2008
Value US$4,301,632.72 | Price 367.38 | Shares 17,459
Buy 23 Jan 2008
Value US$501,251.26 | Price 74.10 | Shares 96,659
Buy 23 Jan 2008
Value US$2,076.80 | Price 2.60 | Shares 800
Buy 23 Jan 2008
Value US$254.00 | Price 2.54 | Shares 100
Buy 23 Jan 2008
Value US$249.00 | Price 2.49 | Shares 100
Buy 23 Jan 2008
Value US$1,244.00 | Price 2.49 | Shares 500
Buy 23 Jan 2008
Value US$1,569.89 | Price 2.48 | Shares 632
Buy 23 Jan 2008
Value US$246.00 | Price 2.46 | Shares 100
Buy 23 Jan 2008
Value US$3,710.00 | Price 2.65 | Shares 1,400
Sale 17 Jan 2008
Value US$1,149,809.59 | Price 76.87 | Shares 42,338
Sale 17 Jan 2008
Value US$2,980,070.12 | Price 382.45 | Shares 39,766
Sale 17 Jan 2008
Value US$516.00 | Price 2.58 | Shares 200
Sale 17 Jan 2008
Value US$506.00 | Price 2.53 | Shares 200
Sale 17 Jan 2008
Value US$750.00 | Price 2.50 | Shares 300
Sale 17 Jan 2008
Value US$1,793.40 | Price 2.45 | Shares 732
Buy 30 Aug 2006
Value US$8,970.00 | Price 2.99 | Shares 3,000
Buy 28 Aug 2006
Value US$7,725.00 | Price 3.09 | Shares 2,500
Buy 22 Aug 2006
Value US$2,934.00 | Price 3.26 | Shares 900
Buy 22 Aug 2006
Value US$327.00 | Price 3.27 | Shares 100
Buy 22 Aug 2006
Value US$3,280.00 | Price 3.28 | Shares 1,000
Buy 4 Oct 2005
Value US$2,140,950.00 | Price 10.50 | Shares 203,900
Buy 4 Oct 2005
Value US$285,705.00 | Price 10.50 | Shares 27,210
Buy 4 Oct 2005
Value US$1,618,995.00 | Price 10.50 | Shares 154,190
Buy 4 Oct 2005
Value US$111,594.00 | Price 10.50 | Shares 10,628
Buy 4 Oct 2005
Value US$1,316,406.00 | Price 10.50 | Shares 125,372
Buy 4 Oct 2005
Value US$18,028.50 | Price 10.50 | Shares 1,717
Buy 4 Oct 2005
Value US$144,847.50 | Price 10.50 | Shares 13,795
Buy 4 Oct 2005
Value US$217,276.50 | Price 10.50 | Shares 20,693
Buy 4 Oct 2005
Value US$1,524,547.50 | Price 10.50 | Shares 145,195
Buy 4 Oct 2005
Value US$285,705.00 | Price 10.50 | Shares 27,210
Buy 4 Oct 2005
Value US$1,618,995.00 | Price 10.50 | Shares 154,190
Buy 4 Oct 2005
Value US$1,070,475.00 | Price 10.50 | Shares 101,950
Buy 4 Oct 2005
Value US$1,070,475.00 | Price 10.50 | Shares 101,950
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
17,459 -22.7%
367.38
US$4,301,633 		17,459 -22.7% 367.38 US$4,301,633
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
96,659 -38.2%
74.10
US$501,251 		96,659 -38.2% 74.10 US$501,251
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
25,452 -18.7%
75.59
US$2,544,978 		25,452 -18.7% 75.59 US$2,544,978
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.54
US$254 		100 +0.5% 2.54 US$254
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.49
US$249 		100 +0.5% 2.49 US$249
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
500 +2.4%
2.49
US$1,244 		500 +2.4% 2.49 US$1,244
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
632 +3.1%
2.48
US$1,570 		632 +3.1% 2.48 US$1,570
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
100 +0.5%
2.46
US$246 		100 +0.5% 2.46 US$246
2008-01-23 2008-01-23 B Purchase Carter Kenneth C

President and CEO

Executive Director
1,400 +7.4%
2.65
US$3,710 		1,400 +7.4% 2.65 US$3,710
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.64
US$528 		200 -0.9% 2.64 US$528
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
400 -1.8%
2.63
US$1,052 		400 -1.8% 2.63 US$1,052
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.58
US$516 		200 -0.9% 2.58 US$516
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
200 -0.9%
2.53
US$506 		200 -0.9% 2.53 US$506
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
300 -1.3%
2.50
US$750 		300 -1.3% 2.50 US$750
2008-01-23 2008-01-17 S Sale Carter Kenneth C

President and CEO

Executive Director
732 -3.1%
2.45
US$1,793 		732 -3.1% 2.45 US$1,793
2006-08-31 2006-08-30 B Purchase Carter Kenneth C

President and CEO

Executive Director
3,000 +14.4%
2.99
US$8,970 		3,000 +14.4% 2.99 US$8,970
2006-08-30 2006-08-28 B Purchase Hamilton J Michael

Chief Medical Officer

Officer
2,500 +1250.0%
3.09
US$7,725 		2,500 +1250.0% 3.09 US$7,725
2006-08-24 2006-08-22 B Purchase Carter Kenneth C

President and CEO

Executive Director
900 +3.8%
3.26
US$2,934 		900 +3.8% 3.26 US$2,934
2006-08-24 2006-08-22 B Purchase Carter Kenneth C

President and CEO

Executive Director
100 +0.4%
3.27
US$327 		100 +0.4% 3.27 US$327
2006-08-24 2006-08-22 B Purchase Carter Kenneth C

President and CEO

Executive Director
1,000 +4.4%
3.28
US$3,280 		1,000 +4.4% 3.28 US$3,280
2005-10-18 2005-10-04 B Purchase EuclidSR Biotechnology Partners, L.P. Non-Executive Director
203,900 +inf%
10.50
US$2,140,950 		203,900 +inf% 10.50 US$2,140,950
2005-10-06 2005-10-04 B Purchase Beneden Patrick Van Non-Executive Director Large shareholder
27,210 +17.6%
10.50
US$285,705 		27,210 +17.6% 10.50 US$285,705
2005-10-06 2005-10-04 B Purchase Beneden Patrick Van Non-Executive Director Large shareholder
154,190 +inf%
10.50
US$1,618,995 		154,190 +inf% 10.50 US$1,618,995
2005-10-06 2005-10-04 B Purchase ROYSTON IVOR Non-Executive Director
10,628 +8.5%
10.50
US$111,594 		10,628 +8.5% 10.50 US$111,594
2005-10-06 2005-10-04 B Purchase ROYSTON IVOR Non-Executive Director
125,372 +inf%
10.50
US$1,316,406 		125,372 +inf% 10.50 US$1,316,406
2005-10-06 2005-10-04 B Purchase OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
1,717 +27.5%
10.50
US$18,028 		1,717 +27.5% 10.50 US$18,028
2005-10-06 2005-10-04 B Purchase OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
13,795 +27.5%
10.50
US$144,848 		13,795 +27.5% 10.50 US$144,848
2005-10-06 2005-10-04 B Purchase OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
20,693 +27.5%
10.50
US$217,276 		20,693 +27.5% 10.50 US$217,276
2005-10-06 2005-10-04 B Purchase OXFORD BIOSCIENCE PARTNERS III LP Large shareholder
145,195 +27.5%
10.50
US$1,524,548 		145,195 +27.5% 10.50 US$1,524,548
2005-10-06 2005-10-04 B Purchase GIMV NV Large shareholder
27,210 +17.6%
10.50
US$285,705 		27,210 +17.6% 10.50 US$285,705
2005-10-06 2005-10-04 B Purchase GIMV NV Large shareholder
154,190 +inf%
10.50
US$1,618,995 		154,190 +inf% 10.50 US$1,618,995
2005-10-06 2005-10-04 B Purchase Whitaker Raymond J Non-Executive Director
101,950 +100.0%
10.50
US$1,070,475 		101,950 +100.0% 10.50 US$1,070,475
2005-10-06 2005-10-04 B Purchase Whitaker Raymond J Non-Executive Director
101,950 +inf%
10.50
US$1,070,475 		101,950 +inf% 10.50 US$1,070,475
Explore more

More insider trading research around Api Acquisition Sub Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America